Hot stocks: SIA, SATS climb as vaccine hopes spur rally

DBS analysts anticipate at least one effective vaccine to be commercialised next year. As such, they accelerated their recovery assumptions, with faster-than-expected mass travel and normalisation kicking in.

bt.sg/4ahB